- $1.84bn
- $2.29bn
- $748.72m
- 67
- 71
- 97
- 92
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Interest Income | |||||
Interest Expense | |||||
Net Interest Income | 427 | 427 | 418 | 495 | 553 |
Loan Loss Provision | |||||
Net Interest Income After Loan Loss Provision | 416 | 418 | 443 | 472 | 528 |
Non Interest Income | |||||
Non Interest Expense | |||||
Net Income Before Taxes | 174 | 190 | 175 | 73.7 | 197 |
Provision for Income Taxes | |||||
Net Income After Taxes | 150 | 160 | 147 | 71.9 | 165 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 150 | 160 | 147 | 71.9 | 165 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 150 | 160 | 147 | 71.9 | 165 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.32 | 3.05 | 2.48 | 2.77 | 2.79 |
Dividends per Share |